RAPT Therapeutics Overview
RAPT Therapeutics Target Price
Analysts' 12-month price predictions for RAPT.
Get informed when a big investor buys or sells
+ FollowShare Price
$58.01
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-01-21 | Barclays | $58 |  0% upside |  |
| 2026-01-21 | Leerink PartnersThomas Smith | $58 | 0% upside | |
| 2026-01-20 | Wells FargoYanan Zhu | $58 | 0% upside | |
| 2026-01-20 | H.C. WainwrightEmily Bodnar | $58 | 0% upside | |
| 2026-01-20 | Piper Sandler | $58 | 0% upside | |
| 2026-01-09 | Piper Sandler | $95 | 63.8% upside | |
| 2025-11-03 | Wells Fargo | $72 | 24.1% upside | |
| 2025-10-27 | H.C. Wainwright | $72 | 24.1% upside | |
| 2025-10-27 | GuggenheimYatin Suneja | $70 | 20.7% upside | |
| 2025-10-13 | Barclays | $35 |  39.7% downside | |
| 2025-09-26 | Leerink Partners | $37 | 36.2% downside | |
| 2025-08-12 | UBSEliana Merle | $9 | 84.5% downside | |
| 2024-11-12 | Leerink PartnersThomas Smith | $2 | 96.6% downside | |
| 2024-11-12 | Stifel NicolausAlex Thompson | $2 | 96.6% downside | |
| 2023-01-04 | Guggenheim | $55 | 5.2% downside | |
| 2023-01-04 | Wells Fargo | $48 | 17.2% downside | |
| 2022-12-08 | Piper SandlerEdward Tenthoff | $33 | 43.1% downside | |
| 2022-12-01 | Goldman Sachs | $27 | 53.5% downside | |
| 2022-11-11 | Piper Sandler | $34 | 41.4% downside | |
| 2022-09-21 | Capital One FinancialZegbeh Jallah | $48 | 17.2% downside | |